Nitric oxide (NO) is an inhibitory neurotransmitter released by non-adrenergic and non-cholinergic neurons that innervate the smooth muscles of the gastrointestinal tract. We examined whether NO, derived from a sustained-release preparation of isosorbide dinitrate, influenced gastric emptying and gastroduodenal motility after a meal. Eleven healthy volunteers participated in a double-blind, placebo-controlled, cross-over study. Each subject ingested 40 mg isosorbide dinitrate orally as a sustained-release formulation or oral placebo, in random order. Gastric emptying and gastroduodenal motility were measured using scintigraphic and manometric techniques. Isosorbide dinitrate did not change the area under the curve of gastric retention versus time, and did not influence the frequency of antral contractions as assessed at 15-min intervals or the integrated duodenal motility index, as recorded over consecutive 15-min periods. A 40 mg single dose of sustained-released isosorbide dinitrate does not seem to alter gastric emptying or gastroduodenal motility after a meal.
Introduction
Nitric oxide (NO) is an important inhibitory neurotransmitter in the gastrointestinal tract. 1, 2 NO produced directly in the muscle cells or as a result of stimulation of nonadrenergic and non-cholinergic vagal neurons activates calcium-dependent potassium channels in the smooth muscle cells, leading to hyperpolarization and relaxation. 3 By reducing the muscle tone, NO modulates gastric motor activity and intestinal peristalsis. 4, 5 In dogs, the inhibition of NO synthesis by N G -nitro-Larginine methyl ester caused suppression of proximal gastric relaxation, stimulation of antral and duodenal motility, and slowing of gastric emptying. 6, 7 The importance of NO mechanisms in the regulation of gastroduodenal motility in humans is, however, uncertain. In healthy volunteers, intravenous infusion of the NO donors isosorbide dinitrate and glyceryl trinitrate has been demonstrated to reduce the gastric emptying rate. 8, 9 In another study, oral administration of isosorbide dinitrate did not influence gastric emptying. 10 Isosorbide dinitrate may be a useful tool in future studies on the significance of NO mechanisms in the control of gastrointestinal motor activity. Knowledge concerning the effect of isosorbide dinitrate on gastroduodenal motor function may therefore be valuable for the planning and interpretation of such investigations.
We evaluated the effect of a sustainedrelease preparation of isosorbide dinitrate on gastric emptying and gastroduodenal motility after a mixed liquid and solid meal in healthy humans.
Subjects and methods

SUBJECTS
This was a placebo-controlled double-blind study of healthy volunteers recruited from Hvidovre Hospital (students and staff) via a poster advertisement. Participants without a history of abdominal surgery (other than appendectomy) and not receiving any medication known to interfere with normal bowel motility were recruited. The local ethics committee approved the study, and all subjects gave written informed consent.
STUDY DESIGN
Each subject underwent paired studies on separate days at least 7 days apart. At 08.00 after an overnight fast, each subject in random order ingested 40 mg isosorbide dinitrate orally as a sustained-release tablet (Cardopax Retard, Orion Pharma, Espoo, Finland) or oral placebo. The placebo tablet comprised calcium carbonate and had the same size and form as the active tablet. The subjects took the tablets while blindfolded to compensate for variations in tablet colour. A manometry catheter was introduced, and pressure recordings were started. Ten minutes after completion of the first duodenal phase III of the migrating motor complex, the subject ingested a radiolabelled meal over 10 min. Sequential scintigraphy was performed and continuous pressure recorded for the following 120 min. Subjects were lying in the supine position with the upper body reclining at approximately 30°d uring the recordings.
MANOMETRY
For duodenal manometry, a multi-lumen water-perfused catheter with an outer diameter of 4.5 mm and side holes incorporated at 3, 13 and 23 cm from the distal tip was used.
The catheter was passed transnasally into the stomach and from there positioned in the duodenum under fluoroscopic control so that the tip of the catheter was located close to the ligament of Treitz. When the correct position had been verified, the catheter was taped to the nose. At the end of the experiment, a repeat fluoroscopic verification of the position of the tube was done. Each lumen of the catheter was connected to a pressure transducer and perfused with distilled water by a low compliance pneumohydraulic perfusion system (Mui Scientific, Mississauga, Ontario, Canada) at a rate of 0.5 ml/min. Outputs from the pressure transducers were recorded using computerized polygraph (UPS2020, Medical Measurement Systems, Enschede, The Netherlands), displayed on a monitor, and stored on a computer for analysis.
Motility patterns were analysed both visually and by means of a computer software package (Medical Measurement Systems, software version 7.1). The duodenal phase III of the migrating motor complex was defined as regular contractile activity at a frequency of 10 -12 contractions/min for at least 2 min, 11 propagated over at least two recording sites. The duodenal motility indexes were calculated over periods of 15 min at the distal recording site 12 after the meal using the following equation:
ln (sum of contraction amplitudes × number of contractions) + 1
SCINTIGRAPHY
Scintigraphy was performed as previously reported with a few modifications. 13, 14 The radiolabelled test meal consisted of mixed liquid and solid components (80 g of bread, 120 g of omelette, 200 g of water) with an energy value of 1700 kJ ; 4 MBq of 111 In-diethylene triamine penta-acetic acid was added to the water as a liquid phase marker and 25 MBq of 99m Tcstannous colloid was added to the omelette as a solid phase marker. Scintigraphy was performed in the left anterior oblique projection with a gamma camera equipped with a medium-energy general-purpose collimator (Starcam 4000i, General Electric Medical Systems, Milwaukee, Wisconsin, USA). Dynamic frames (128 × 128 pixel matrix) of 1 s each were acquired over 5 min at 15 min intervals over a period of 120 min using a 15% window centred on the 140 keV 99m Tc photopeak and 15% and 20% windows centred on the 174 and 247 keV 111 In photopeaks, respectively.
For the assessment of gastric emptying, the first 120 images of each set of dynamic acquisitions were reframed into one single image. Regions of interest for the integration of radioactivity were drawn manually around the stomach on each reframed image. After correction for physical decay and downscatter of 111 In radioactivity into the 99m Tc window, the percentage meal retention was calculated separately for the liquid and solid phase markers at each time interval, and the area under the curve of gastric retention versus time was determined.
The frequency of antral contractions was derived from the dynamic acquisitions using the principle described previously. 14 
STATISTICAL ANALYSIS
Results were given as the mean ± SD. Analysis of the effects of isosorbide dinitrate was carried out using the paired samples t-test. Differences were considered significant when P < 0.05.
Results
Eleven healthy volunteers (four women, seven men; age range 2 -50 years) participated in the study.
The results of the gastric emptying measurements are shown in Figs 1 and 2.
The area under the curve of gastric retention versus time for the liquid marker was 93 ± 17%h after isosorbide dinitrate and 96 ± 27%h after placebo. For the solid marker the corresponding areas were 140 ± 22%h and 141 ± 26%h, respectively. These results were not statistically different, indicating that the process of gastric emptying was not influenced by the ingestion of isosorbide dinitrate.
The antral contraction frequency and duodenal motility index results are given in Figs 3 and 4 . Multiple comparisons showed that the frequencies and motility indexes were not changed by isosorbide dinitrate at any time point or over any 15-min period, respectively.
Discussion
The migrating motor complex is a cyclic interdigestive motility pattern of the stomach and small intestine. It is characterized by three different phases: phase I with no contractions, phase II with contractions at an irregular frequency and phase III with regular contractions at a slow-wave frequency. 15 The migrating motor complex is associated with cyclic variations in gastric and pancreatic secretion, gall bladder emptying and splanchnic blood flow. 16 When meals are ingested, the migrating motor complex is Various studies have indicated a complex interplay between the migrating motor complex and the post-prandial state, suggesting that the migrating motor complex clock still runs during the post-prandial period. The preceding phase of the migrating motor complex seems to modulate the postprandial endocrine response in the gastrointestinal tract, 17, 18 leading to faster gastric emptying after meal consumption during intestinal phase II than during phase I. 19 To reduce the intra-subject variability in gastric emptying and gastroduodenal motility, the subjects in our study ingested the test meal at the end of a duodenal phase III. This phase of the migrating motor complex lasts for only a few minutes and is easily recognized on manometrical recordings. Despite this precaution, we did not detect any effect of a 40 mg single dose of a sustained-release formulation of isosorbide dinitrate on gastric emptying, the frequency of antral contractions or the duodenal motility index after a meal.
Isosorbide dinitrate is a lipophilic substance that is quickly absorbed from the gastrointestinal tract. 20 After the ingestion of a sustained-release tablet of isosorbide dinitrate, the pharmacological effective plasma concentration of this drug is reached in 15 -30 min and maintained for the following 8-to 12-h period. The peak plasma level is reached in 30 -60 min. Sustained-release preparations of isosorbide dinitrate, therefore, seem to be more appropriate NO donors for studying the effects of NO on gastrointestinal motor activity than the short-acting forms of glyceryl nitrates. In the present study, the plasma concentration of isosorbide dinitrate was not measured and it could, therefore, be argued that the negative results were due to inadequate release of isosorbide dinitrate during the recordings. Theoretically, gastric retention of the tablet might have caused a delayed increase in the plasma concentration of the NO donor in some cases due to possible differences in gastric and small intestinal absorption capacity of released isosorbide dinitrate. However, in all cases the motility recordings began at least 60 min after intake of the tablet and after the occurrence of phase III of the migrating motor complex. Larger indigestible components of a meal as well as undissolved tablets are known to be cleared from the stomach during phase III of the migrating motor complex, 21 and it is, therefore, reasonable to suggest that the sustained-release tablets of isosorbide dinitrate were located in the small bowel during all the motility recordings.
To the best of our knowledge, only two previous studies have addressed the effect of sublingual or oral isosorbide dinitrate on gastric emptying in healthy subjects. Matsuda et al. 22 found that 5 mg of sublingual isosorbide dinitrate did not influence gastric emptying of a liquid meal. The other study, performed by Stacher et al., 10 showed that 20 or 40 mg of sustained-release preparations of isosorbide dinitrate did not change the gastric emptying of a semisolid meal. The present observation is consistent with these previous reports.
Slow waves are the normal spontaneous oscillations in the membrane potential of smooth muscle cells and provide the basic electrical rhythm of the gastrointestinal tract. Pacemaker cells in the enteric nervous system regulate the slow-wave activity, which, in turn, regulates the frequency of gastrointestinal muscle contractions. Due to the hyperpolarizing effect of NO on smooth muscle cell membrane potentials, it is reasonable to assume that the presence of NO donors or inhibition of endogenous NO production will influence the frequency of the slow waves. The NO donor sodium JL Madsen, SL Rasmussen, J Linnet et al.
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nitroprusside was shown to increase the slow-wave frequency in smooth muscle cells isolated from the gastric antrum of guinea pigs; 23 however, it was likely that this effect was related to a chemical action of the sodium nitroprusside molecule per se rather than being due to NO. Measurements of myoelectrical activity in healthy humans have shown that N G -monomethyl-L-arginine, an inhibitor of endogenous NO synthesis, does not change the frequency of gastric slow waves. 24 Assuming gastric antral contraction frequency reflects gastric slow wave frequency, our observation that NO donor did not influence gastric antral contraction frequency confirmed that NO has no major impact on normal human gastric slow wave or pacemaker cell activity.
Mechanisms involving NO have been demonstrated to play a role in the regulation of interdigestive small intestinal motor activity in humans. Inhibition of NO synthesis is associated with stimulation of phase III activity of the migrating motor complex and a reduction in quiescence after this premature activity. 25, 26 The influence of NO on small intestinal motility after a meal, however, remains to be clarified. In four of the 10 subjects who participated in the investigation performed by Kuiken et al., 26 the normal post-prandial motility pattern was interrupted by phase III-like activity. Such changes were not observed during the post-prandial recording period in any of our subjects; on the contrary, we found that isosorbide dinitrate did not change the duodenal motility index after a meal, a finding that seems to be in accordance with the observations made by Su et al. 27 In their study, intravenous administration of a NO synthase inhibitor did not modify the frequency of duodenal pressure waves after intraduodenal infusion of lipids.
Few studies have addressed the effect of the NO donor isosorbide dinitrate on gastrointestinal motility in healthy humans; to our knowledge, the effect of this drug on post-prandial small bowel motility has not been evaluated previously. In our study, the dose of NO donor used had no significant impact on gastric or duodenal motor function after a meal. This dose of isosorbide dinitrate is known to induce an increase in local NO level that reduces smooth muscle tone in atherosclerotic coronary arteries. It is possible, however, that relaxation of gastrointestinal smooth muscle cells in healthy humans requires a higher dose of isosorbide dinitrate.
In conclusion, a 40 mg single dose of a sustained-release preparation of isosorbide dinitrate did not alter post-prandial gastric emptying, frequency of antral contractions or duodenal motility in healthy humans.
